Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
Yukio Sassa, Yasuaki HataDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Age-related macular degeneration (AMD) complications are the leading cause of severe vision loss among the aging population in the many western countries. The introdu...
Enregistré dans:
Auteurs principaux: | Yukio Sassa, Yasuaki Hata |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b76f7850d4434736b3bbd437ed9e89ab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Use of antivascular endothelial growth factor for diabetic macular edema
par: Rushmia Karim, et autres
Publié: (2010) -
Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
par: Carreras A, et autres
Publié: (2012) -
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
par: Asahi MG, et autres
Publié: (2017) -
Treatment of retinal pigment epithelial detachment with antiangiogenic therapy
par: Luis Arias
Publié: (2010) -
Emerging roles for antiangiogenesis factors in management of ocular disease
par: Saeed MU, et autres
Publié: (2013)